Clinical Trial Update: Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 clinical trial evaluating aprepitant for the prevention of chemotherapy-induced nausea and vomiting. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chemotherapy-Induced Nausea and Vomiting | Phase 3 | Status: COMPLETED | Results posted: 2009-11-06